HOME >> MEDICINE >> NEWS
Study shows new imaging tracer clarifies cause of chest pain up to 30 hours after pain stops

A national team of researchers, led by a cardiovascular nuclear medicine specialist at the University of Maryland Medical Center, has demonstrated for the first time that an experimental radioactive compound can show images of heart damage up to 30 hours after a brief interruption of blood flow and oxygen. The discovery may help physicians in emergency rooms and in their offices determine whether a patient's chest pain, which may have subsided hours earlier, is related to heart disease or something else, such as indigestion. The results of the study appear today in Circulation Online and will appear in the print version of Circulation on October 4, 2005.

"We are excited about this agent because it extends the time window for identifying myocardial ischemia, a common cause of chest pain, long after the pain stops and blood flow to the heart returns to normal," says lead investigator Vasken Dilsizian, M.D., professor of medicine and diagnostic radiology and nuclear medicine at the University of Maryland School of Medicine and director of Cardiovascular Nuclear Medicine at the University of Maryland Medical Center. "This probe provides a direct connection to the cause of the chest pain without requiring a treadmill stress test or use of a drug that produces stress to assess heart function," says Dr. Dilsizian.

Nuclear medicine combines computers, detectors and radioactive substances called radioisotopes to produce images of blood flow and biochemical functions in the heart and other organs. The radioactive tracer evaluated for this study, known by the brand name Zemiva, links a fatty acid to a radioisotope which is injected in the patient. The researchers used a technique called SPECT (Single Photon Emission Computed Tomography) to evaluate the tracer in this study.

The heart normally uses fatty acid as its primary fuel source for energy. Decreased blood flow to the heart, caused either by narrowed or clogged arteries or increased demand on
'"/>

Contact: Bill Seiler
bseiler@umm.edu
410-328-8919
University of Maryland Medical Center
26-Sep-2005


Page: 1 2 3

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... The Quatela ... It is the first and only nonsurgical product approved by the Food and ... Dr. Vito Quatela and Dr. William Koenig are among the premier ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... to distributing health information technology innovation to transform quality and efficiency of healthcare ... survey will be de-identified and aggregated before being publicly shared to document progress ...
(Date:8/28/2015)... ... 2015 , ... External Counterpulsation, also known as ECP or EECP, is a ... (EECP or ECP) machines with a full clinic licence to help people prevent and ... helping people prevent and reverse heart disease through its evidence-based integrative approach ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new ... and updated navigation. The most notable change is the responsive web design. Website users ... devices. Customers can easily submit quote requests for sod, sign-up for the monthly turf-tips ...
(Date:8/28/2015)... ... ... 3, 2015, BethAnn Telford of TeamBT and Maria Parker of 3000MilesToACure ... to beat brain cancer. In one grueling day, they will race Rim-to-Rim: from the ... Rim over 21.1 miles and more than 10,000 feet of elevation change. , BethAnn ...
Breaking Medicine News(10 mins):Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:Women Athletes Cross the Grand Canyon to Raise Funds for Brain Cancer Research – October 3rd 2
(Date:8/27/2015)... 27, 2015  A mere one in seven new ... Hamilton . A new white paper from ... impeding and disrupting manufacturers, success. The white ... Value In Product Development Processes provides insight into: ... how it affects the product development process resulting in: ...
(Date:8/27/2015)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCQB: GNBT) today announced the issuance of ... the Company,s proprietary buccal insulin spray product.  The white ... meeting of the Company,s stockholders by Dr. James ... Advisor.  The white paper may be viewed online on ...
(Date:8/27/2015)... , Aug. 27, 2015  PinnacleHealth CardioVascular Institute enrolled the ... in the United States in a ... of stent for blockages in the main artery of the ... artery and potentially less risk for stent fracture or re-narrowing ... prospective, single-arm, multicenter clinical trial of the BioMimics 3D Stent ...
Breaking Medicine Technology:New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4First Pennsylvania Patient Treated in Landmark Vascular Study 2
Cached News: